Range
130.48 - 138.93
Vol / Avg.
737.2K/2.3M
Div / Yield
-
52 Wk
16.54 - 202.73
Mkt Cap
9.8B
Payout Ratio
-
Open
132.01
P/E
-
EPS
-0.69
Shares
72.3M
Outstanding
72.3M
Total Float
59.9M
Benzinga - Jun 29, 2021, 6:58AM
load more
Sector: Health Care.Industry: Biotechnology
Intellia Therapeutics Inc is a genome editing company. It is focused on developing proprietary, potentially curative CRISPR/Cas9-based therapeutics. Its pipeline includes in vivo development programs targeting genetic diseases, including transthyretin amyloidosis and hereditary angioedema, and ex vivo programs which include Acute Myeloid Leukemia.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.670-0.690 -0.0200
REV8.570M6.445M-2.125M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NTLAIntellia Therapeutics0%9.8B

Intellia Therapeutics Frequently Asked Questions

Q

How do I buy Intellia Therapeutics (NTLA) stock?

A

You can purchase shares of Intellia Therapeutics (NASDAQ: NTLA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intellia Therapeutics's (NTLA) competitors?

Q

What is the target price for Intellia Therapeutics (NTLA) stock?

A

The latest price target for Intellia Therapeutics (NASDAQ: NTLA) was reported by Oppenheimer on June 29, 2021. The analyst firm set a price target for 125.00 expecting NTLA to fall to within 12 months (a possible -8.20% downside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intellia Therapeutics (NTLA)?

A

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $136.17 last updated Today at 8:00:02 PM.

Q

Does Intellia Therapeutics (NTLA) pay a dividend?

A

There are no upcoming dividends for Intellia Therapeutics.

Q

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

A
Intellia Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Intellia Therapeutics (NTLA) going to split?

A

There is no upcoming split for Intellia Therapeutics.

Q

What sector and industry does Intellia Therapeutics (NTLA) operate in?

A

Intellia Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.